Tandem Diabetes Care: Q4 Earnings Insights

Comments
Loading...

Tandem Diabetes Care TNDM reported its Q4 earnings results on Wednesday, February 21, 2024 at 04:05 PM.

Here's what investors need to know about the announcement.

Earnings

Tandem Diabetes Care missed estimated earnings by 8.0%, reporting an EPS of $-0.27 versus an estimate of $-0.25.

Revenue was down $23.71 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.04 which was followed by a 14.37% drop in the share price the next day.

Here's a look at Tandem Diabetes Care's past performance:

Quarter Q3 2023 Q2 2023 Q1 2023 Q4 2022
EPS Estimate -0.34 -0.53 -0.52 -0.06
EPS Actual -0.38 -0.30 -0.63 -0.01
Revenue Estimate 192.34M 197.64M 170.23M 221.83M
Revenue Actual 185.62M 195.92M 169.38M 220.50M

To track all earnings releases for Tandem Diabetes Care visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise

Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!